A Phase III Study to Evaluate Bremelanotide in Women with Female Sexual Dysfunction.
Phase of Trial: Phase III
Latest Information Update: 13 May 2015
At a glance
- Drugs Bremelanotide (Primary)
- Indications Female sexual dysfunction
- Focus Therapeutic Use
- 13 May 2015 According to a Palatin Technologies media release, Palatin plans to initiate this trial later in 2015 in Europe.
- 13 May 2015 New trial record